Robert J DelAversano

CIK 1728262 · Principal Financial Officer · last filed 2025-04-16

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

15

Lifetime Open-Market Net

-$4.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GRCE Principal Financial Officer $2.20 $0 1 2025-04-16
Grace Therapeutics, Inc. (ACST) Delisted Principal Financial Officer $3.37 $0 1 2024-05-08
ONCOSEC MEDICAL Inc (ONCS) Delisted VP, Finance 1,008 $0.28 $279 -$4.6K 12 2023-02-09
USAU See Remarks $15.36 $0 1 2018-04-12

Recent Filings · Page 2 of 2

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-05-04 ONCOSEC MEDICAL Inc (ONCS) Delisted Sell (S) −453 -$2.2K EDGAR
2021-02-03 ONCOSEC MEDICAL Inc (ONCS) Delisted Grant (A) +8,750 $0 EDGAR
2020-08-26 ONCOSEC MEDICAL Inc (ONCS) Delisted Grant (A) $0 EDGAR
2020-06-03 ONCOSEC MEDICAL Inc (ONCS) Delisted Mixed +16,683 -$19.4K EDGAR
2018-04-12 USAU Grant (A) $0 EDGAR
Showing 1115 of 15
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.